Article Information
- Received June 20, 2014
- Revision received October 8, 2014
- Accepted October 14, 2014
- First published November 26, 2014.
- Version of record published November 26, 2014.
Author Information
Author contributions
Author contributions: A.N.C., B.B.S., P.S.E., R.B., and D.C.Z. designed research; A.N.C., B.B.S., P.S.E., J.J., T.K., and A.P. performed research; S.G.D. and A.P. contributed unpublished reagents/analytic tools; A.N.C., P.S.E., R.B., and D.C.Z. analyzed data; A.N.C., R.B., and D.C.Z. wrote the paper.
Disclosures
- Received June 20, 2014.
- Revision received October 8, 2014.
- Accepted October 14, 2014.
This work was supported by NIH Grants NS078429 (D.C.Z.) and NS061867 (R.B.) and MDA Grant 255293 (D.C.Z.). Additional funds were provided by the Himelic Family Foundation, the Neuroscience Graduate Interdisciplinary Program at the University of Arizona (A.N.C.), and the Beckman Foundation (A.P.). The 22C10 monoclonal antibody was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by the Department of Biology, The University of Iowa (Iowa City, IA). We thank members of the Zarnescu laboratory and Ross Buchan for helpful suggestions on this manuscript.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Daniela C. Zarnescu at the above address. zarnescu{at}email.arizona.edu
Online Impact
Article usage
In this issue
